Henry Schein Dental To Showcase The Company's Expansive Portfolio Of Solutions At Chicago Midwinter Dental Meeting

Go back to Henry Schein Dental To Showcase The Company's Expansive Portfolio Of Solutions At Chicago Midwinter Dental Meeting

Henry Schein (HSIC) PT Lowered to $57 at UBS

February 25, 2019 7:11 AM EST

UBS analyst Kevin Caliendo lowered the price target on Henry Schein (NASDAQ: HSIC) to $57.00 (from $59.00) while maintaining a Sell rating.

... More

Henry Schein (HSIC) PT Lowered to $65 at Stifel

February 21, 2019 9:11 AM EST

Stifel analyst Jonathan Block lowered the price target on Henry Schein (NASDAQ: HSIC) to $65.00 (from $85.00) while maintaining a Hold rating following the company's 4Q. Results were lighter than expected. Adjusted internal sales growth of +2.6% was below +4.8% estimates, and the 4Q18 two-year stacked adjusted... More

Henry Schein (HSIC) PT Lowered to $59 at Baird

February 21, 2019 8:54 AM EST

Baird analyst Jeff Johnson lowered the price target on Henry Schein (NASDAQ: HSIC) to $59.00 (from $66.00) while maintaining a Neutral rating. Organic revenue growth of +3.1% finished above pre-call estimates of +2.4%. However, organic growth in two of HSIC's higher-margin segments finished below expectations, contributing... More